GHSR‐Foxo1 Signaling in Macrophages Promotes Liver Fibrosis via Inflammatory Response and Hepatic Stellate Cell Activation

Abstract Liver fibrosis is a severe liver disease directly linked to chronic inflammation, in which hepatic macrophages play a key role. Growth hormone secretagogue receptor (GHSR) is the receptor of nutrient‐sensing hormone ghrelin that has essential functions in metabolism, inflammation, and wound‐healing. However, the role of GHSR in liver fibrosis is unknown. This study uses a carbon tetrachloride (CCl 4 )‐induced liver fibrosis mouse model to investigate the role of macrophage GHSR in liver fibrosis. CCl 4 induces macrophage accumulation and inflammatory responses, noticeably increases GHSR expression in the liver. It is found that macrophage Ghsr deletion ( Ghsr‐MϕKO ) attenuates CCl 4 ‐induced liver fibrosis and inflammation, showing reduced hepatic monocyte‐derived macrophages (MDMs) and suppressed proinflammatory responses. In macrophages, transforming growth factor (TGF)‐β1 expression is positively correlated with GHSR expression. GHSR‐associated TGF‐β1 in macrophages activates hepatic stellate cells (HSCs) by promoting the crosstalk between macrophages and HSCs. Macrophage GHSR controls inflammation and TGF‐β1 expression via protein kinase A (PKA)‐mediated Forkhead box protein O 1 (Foxo1) phosphorylation at S273; Foxo1‐S273D mutation, mimicking constitutive phosphorylation of Foxo1 at S273, shows exacerbated CCl 4 ‐induced liver inflammation and fibrosis. Thus, targeting the macrophage GHSR−Foxo1 signaling may provide a new strategy to treat liver fibrosis.